Ceftriaxone in Non-neutropenic Fever

Status Completed

Clinical Trial Summary

This is a retrospective chart review of all patients cared for at Monroe Carell Jr. Children's Hospital at Vanderbilt including the following:

- patients between 2007-2009 with malignancy, Langerhans cell histiocytosis (LCH) or hemophagocytic lymphohistiocytosis (HLH) and a central venous catheter who were under 23 years of age at time of diagnosis in order to ascertain the associated symptoms, management and outcome of all episodes of non-neutropenic fever.

- to identify a subset of low-risk patients that can be safely managed without use of empiric antibiotics.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01225718
Study type	Observational
Source	Vanderbilt University Medical Center
Contact
Status	Completed
Phase	N/A
Start date	August 2010
Completion date	June 25, 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01049854` - CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant	Phase 2
Recruiting	`NCT05915208` - Histiocytic Disorder Follow-up Study
Recruiting	`NCT04437381` - Molecular Targets for the Treatment of Histiocytosis
Terminated	`NCT01050439` - Unrelated Donor Transplant for Malignant and Non-Malignant Disorders	Phase 2
Active, not recruiting	`NCT00145626` - HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies	Phase 2
Not yet recruiting	`NCT05803629` - Characterizing Histiocytosis With 68Ga-FAPI PET/CT	N/A
Recruiting	`NCT04665674` - Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study
Terminated	`NCT02012231` - Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.	Phase 1
Active, not recruiting	`NCT03127709` - A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis
Recruiting	`NCT05786924` - A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers	Phase 1
Recruiting	`NCT04943224` - Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients	Phase 2
Recruiting	`NCT04943198` - Optimization of the Time and Dosage of Vemurafenib in BRAF Positive Juvenile Patients With Refractory Histiocytosis	Phase 2
Recruiting	`NCT04943211` - Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging	Phase 3